发明授权
US08299241B2 Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
失效
制备(R)-8-氯-1-甲基-2,3,4,5-四氢-1H-3-苯并氮杂的方法及其中间体
- 专利标题: Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
- 专利标题(中): 制备(R)-8-氯-1-甲基-2,3,4,5-四氢-1H-3-苯并氮杂的方法及其中间体
-
申请号: US12517625申请日: 2007-12-04
-
公开(公告)号: US08299241B2公开(公告)日: 2012-10-30
- 发明人: Tawfik Gharbaoui , Sagun K. Tandel , You-An Ma , Marlon Carlos , John Robert Fritch
- 申请人: Tawfik Gharbaoui , Sagun K. Tandel , You-An Ma , Marlon Carlos , John Robert Fritch
- 申请人地址: US CA San Diego
- 专利权人: Arena Pharmaceuticals, Inc.
- 当前专利权人: Arena Pharmaceuticals, Inc.
- 当前专利权人地址: US CA San Diego
- 代理机构: Foley & Lardner LLP
- 国际申请: PCT/US2007/024900 WO 20071204
- 国际公布: WO2008/070111 WO 20080612
- 主分类号: C07C233/22
- IPC分类号: C07C233/22 ; C07C231/02 ; C07C209/50 ; C07D263/10 ; C07D223/16
摘要:
The present invention provides processes and intermediates for the preparation of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and salts thereof which are useful as serotonin-2C (5-HT2C) receptor agonists for the treatment of, for example, obesity.